Hydrocortisone for BPD

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

August 11, 2011

Primary Completion Date

September 21, 2020

Study Completion Date

September 12, 2024

Conditions
Infant, NewbornInfant, Small for Gestational AgeInfant, Very Low Birth WeightInfant, PrematureBronchopulmonary Dysplasia
Interventions
DRUG

Hydrocortisone

"Hydrocortisone sodium succinate for intravenous administration (unpreserved, Solu-Cortef plain, Pfizer®, reconstituted with unpreserved normal saline to avoid exposure to the benzyl alcohol contained in preserved diluents), to be administered either intravenously or orally if no intravenous line is available at the same dose, and tapered as follows:~4mg/kg/day ¸ q 6 hours x 2 days, then 2mg/kg/day ¸ q 6 hours x 3 days; then~1mg/kg/day ¸ q 12 hours x 3 days; then 0.5mg/kg/d as a single dose x 2 days"

DRUG

Placebo

"Saline placebo to be administered either intravenously or orally if no intravenous line is available, at the same dose, and tapered as follows:~4mg/kg/day ¸ q 6 hours x 2 days, then 2mg/kg/day ¸ q 6 hours x 3 days; then~1mg/kg/day ¸ q 12 hours x 3 days; then 0.5mg/kg/d as a single dose x 2 days"

Trial Locations (20)

14642

University of Rochester, Rochester

19104

Univeristy of Pennsylvania, Philadelphia

27705

RTI International, Durham

27710

Duke University, Durham

30303

Emory University, Atlanta

35233

University of Alabama at Birmingham, Birmingham

43205

Research Institute at Nationwide Children's Hospital, Columbus

44106

Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland

45267

Cincinnati Children's Medical Center, Cincinnati

46202

Indiana University, Indianapolis

48201

Wayne State University, Detroit

52242

University of Iowa, Iowa City

64108

Children's Mercy Hospital, Kansas City

75235

University of Texas Southwestern Medical Center at Dallas, Dallas

77030

University of Texas Health Science Center at Houston, Houston

84108

University of Utah, Salt Lake City

87131

University of New Mexico, Albuquerque

90025

University of California - Los Angeles, Los Angeles

94304

Stanford University, Palo Alto

02905

Brown University, Women & Infants Hospital of Rhode Island, Providence

All Listed Sponsors
collaborator

National Center for Research Resources (NCRR)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

NICHD Neonatal Research Network

NETWORK

NCT01353313 - Hydrocortisone for BPD | Biotech Hunter | Biotech Hunter